08:07 AM EDT, 05/07/2024 (MT Newswires) -- Ionis Pharmaceuticals ( IONS ) reported a Q1 net loss Tuesday of $0.98 per diluted share, widening from a loss of $0.87 a year earlier.

Analysts polled by Capital IQ expected a loss of $1.07.

Revenue for the quarter ended March 31 was $119 million, down from $131 million a year earlier.

Analysts surveyed by Capital IQ expected $136.4 million.